Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance    WBA

WALGREENS BOOTS ALLIANCE

(WBA)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Walgreens Boots Alliance : Sales Growth Falls Short -- 2nd Update

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/11/2018 | 01:39pm EDT

By Kimberly Chin

Walgreens Boots Alliance Inc. said growth in prescription volumes helped lift pharmacy sales in its latest quarter, as the company's integration of Rite Aid stores expanded its foothold in the U.S. prescription market.

Walgreens's share of the U.S. retail prescription market this year has grown to a company record 21.7%, compared with 20.2% in 2017, Walgreens Chief Financial Officer James Kehoe said Thursday, citing data from health-care research firm Iqvia.

For the fourth quarter, Walgreens said it had filled the largest number of prescriptions in its 117-year history, largely because of its retention of many Rite Aid prescription-drug customers after taking over those stores. Walgreens closed a $4.4 billion deal earlier this year to buy more than 1,900 pharmacies from Rite Aid Corp.

Walgreens, based in Deerfield, Ill., said U.S. pharmacy sales rose 17% from the year-earlier quarter while prescriptions filled in comparable stores increased 1.3%. Overall sales rose 11% to $33.44 billion, though analysts had expected Walgreens to report $33.78 billion in sales based on a Refinitiv poll.

The drugstore chain has engaged in several deals and partnerships with the aim of expanding its pharmacy business to become a "health-care destination" for health, beauty and personal care, said Chief Executive Stefano Pessina.

Walgreens reached a deal in September to buy customer files from a group of stores that are part of the Fred's Inc. drugstore chain. This month, Walgreens said it would work with clinical-lab operator LabCorp, known formally as Laboratory Corp. of America Holdings, to open at least 600 LabCorp patient centers at its stores over the next four years. It also reached an agreement with Kroger Co., the nation's largest supermarket chain, to work together to pilot a new store format. The company has also looked to boost its beauty aisles with high-end cosmetics after taking a minority stake in beauty startup Birchbox Inc.

Growth in Walgreens's pharmacy business helped offset weakness in sales of general merchandise and personal-care items. Comparable retail sales in the fourth quarter fell 1.9% from a year earlier in the U.S., and 0.9% in the company's international segment on a constant-currency basis. The company has more than 18,500 stores across 11 countries.

Shares in Walgreens were up 1.5% at $73.40 at midday Thursday.

Net income for the company rose 89% to $1.51 billion, or $1.55 a share. On an adjusted basis, earnings per share came in at $1.48, above the $1.45 expected by analysts.

For the current fiscal year Walgreens forecast earnings growth between 7% and 12% at constant currency rates, and adjusted earnings per share in the range of $6.40 to $6.70. Analysts expect adjusted earnings of $6.45 a share.

Write to Kimberly Chin at kimberly.chin@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
WALGREENS BOOTS ALLIANCE 0.31% 51.77 Delayed Quote.-24.24%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE
05/21KROGER : Loop Launches in U.S., Announces Kroger and Walgreens as Founding Retai..
DJ
05/17WALGREENS BOOTS ALLIANCE : Ex-dividend day for
FA
05/13WALGREENS BOOTS ALLIANCE : Announces Collaboration for Cancer Prevention, Resear..
BU
05/08Walmart raises U.S. tobacco purchase age to 21 starting in July
RE
05/02WALGREENS BOOTS ALLIANCE : Texas Markets Top Walgreens Flu™ Index for Over..
BU
05/02CVS HEALTH : Eases Doubts About Aetna Acquisition
DJ
05/01CVS HEALTH : Eases Concerns About Aetna Deal --Update
DJ
05/01CVS HEALTH : Eases Concerns About Aetna Deal --Update
DJ
05/01WALGREENS : Forms Unique Collaboration with National Council for Behavioral Heal..
BU
04/25WALGREENS BOOTS ALLIANCE : Announces Key Leadership Appointments
PU
More news
Financials ($)
Sales 2019 137 B
EBIT 2019 7 187 M
Net income 2019 4 581 M
Debt 2019 14 957 M
Yield 2019 3,48%
P/E ratio 2019 10,21
P/E ratio 2020 9,55
EV / Sales 2019 0,46x
EV / Sales 2020 0,43x
Capitalization 47 333 M
Chart WALGREENS BOOTS ALLIANCE
Duration : Period :
Walgreens Boots Alliance Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Average target price 58,0 $
Spread / Average Target 12%
EPS Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
Richard M. Ashworth President-Operations
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIANCE-24.24%47 333
MCKESSON CORPORATION17.61%24 680
AMERISOURCEBERGEN8.44%16 957
CARDINAL HEALTH3.03%13 696
SINOPHARM HOLDING CO LTD-12.01%10 975
SHANGHAI PHARMACEUTICALS HOLDING CO LTD8.65%6 935